Recently, Ulrich et al. (65) highlighted that the protein receptor CD147, considered a novel route for SARS-CoV-2 invasion, could be a target for COVID-19 treatment, since azithromycin is supposed to limit endocytosis in macrophages via inhibition of CD147. The gene discussed is BSG; the disease is COVID-19.